Extendicare Announces Appointment of Michael Guerriere to Board of Directors
Mar 12, 2018 12:01 pm UTC| Business
MARKHAM, Ontario, March 12, 2018 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) today announced the appointment of Michael Guerriere to its Board of Directors, effective immediately, for a term to expire...
Mar 12, 2018 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 12, 2018 -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq:GBT), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics...
Scout Exchange Announces $100M in Funding to Accelerate Growth of Recruitment Marketplace
Mar 12, 2018 12:01 pm UTC| Business
BOSTON, MA, March 12, 2018 -- Scout Exchange, a platform for marketplace recruiting, today announced it has received $100 million in funding from TRI Ventures, the investment vehicle of creative staffing industry...
CUV Ventures Corp Update On The Revolupay Remittance App
Mar 12, 2018 12:01 pm UTC| Business
VANCOUVER, British Columbia, March 12, 2018 -- CUV Ventures Corp. (TSX-V:CUV) (Berlin:A2JE7L) (the “Company”) is pleased to provide shareholders with a corporate update concerning the Revolupay Apple and Android...
Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura
Mar 12, 2018 12:01 pm UTC| Business
Sollpura did not achieve the primary endpoint of the coefficient of fat absorption (“CFA”)Sollpura did achieve the secondary endpoint of coefficient of nitrogen absorption (“CNA”)Further development of Sollpura to be...
Rockwell Medical Schedules Year End 2017 Earnings Call
Mar 12, 2018 12:01 pm UTC| Business
WIXOM, Mich., March 12, 2018 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Mar 12, 2018 12:01 pm UTC| Business
Median overall survival of 23.7 months following CMB305 monotherapy represents approximately one-year extension of survival compared to published data in soft tissue sarcoma patient populationObjective response rate (ORR)...